Original Source(s)
Related Content
Vamikibart Shows Early Safety in Uveitic Macular Edema
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026
-
3 min